The US Food and Drug Administration delivers on its plan for a "rapid response tool" to identify and publish ingredients the agency says could be ineligible for use in dietary supplements. The tool doesn't, however, deliver brand names or identify firms marketing products containing the ingredients.
The FDA announced the addition of the Dietary Supplement Ingredient Advisory List to its website on April 16 with four ingredients – andarine, higenamine, hordenine and 1,4-DMAA– that the agency has preliminarily determined should not be used vitamin, minerla or supplement products because they are not dietary ingredients or are new dietary ingredients that have not been notified to the agency with proof of a reasonable expectation of safety for their intended use
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?